Mobile

Second meningococcal vaccination in Dutch children: Study to compare the tetravalent MenACWY-TT conjugate vaccine with the monovalent MenC-TT conjugate vaccine. Tweede meningokokken vaccinatie b...

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-001823-38

Second meningococcal vaccination in Dutch children: Study to compare the tetravalent MenACWY-TT conjugate vaccine with the monovalent MenC-TT conjugate vaccine. Tweede meningokokken vaccinatie bij nederlandse kinderen: Een onderzoek waarbij het tetravelente MenACWY-TT vaccin vergeleken zal worden met het monovalente MenC-TT vaccin

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to demonstrate non-inferiority of SBA levels against MenC at 1 year (T2) after vaccination in the group vaccinated with tetravalent MenACWY-TT vaccine as compared with the group vaccinated with monovalent MenC-TT conjugate vaccine in 10-, 12-, and 15-years old children. If non-inferiority is demonstrated, the objective is to compare SBA levels against MenA, MenW and MenY at 1 year (T2) after vaccination between the three age groups that are vaccinated with tetravalent MenACWY-TT vaccine.

Critère d'inclusion

  • The monovalent MenC-TT vaccin administered in this study is used to prevent invasive disease caused by Meningococcal group C. The tetravelent MenACWY-TT vaccin administered in this study is used to prevent invasive disease caused by Meningococcal serogroup A, C, W and Y,Het monovalente MenC-TT vaccine beschermt tegen invasieve meningokokkenziekte van type C. Het tetravalente MenACWY-TT vaccine beschermt tegen invasieve meningokokkenziekte van type A, C, W en Y

Liens